Results 51 to 60 of about 648,089 (387)

A rhodanine agent active against non-replicating intracellular Mycobacterium avium subspecies paratuberculosis. [PDF]

open access: yes, 2009
BACKGROUND: Antibiotic therapy targeting chronic mycobacterial disease is often ineffective due to problems with the emergence of drug resistance and non-replicating persistent intracellular antibiotic resistant phenotypes.
Bull, TJ   +3 more
core   +3 more sources

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

open access: yesJournal of Experimental Medicine, 1993
Tuberculosis, a major health problem in developing countries, has reemerged in recent years in many industrialized countries. The increased susceptibility of immunocompromised individuals to tuberculosis, and many experimental studies indicate that T ...
J. Flynn   +5 more
semanticscholar   +1 more source

Exploring clues for wide variations in COVID-19 fatality rates among countries

open access: yesMGM Journal of Medical Sciences, 2022
COVID-19 flu has been the worst pandemic on earth in more than a century and has thus far claimed more than six million lives worldwide. As of 19th March 2022, there were 57 major countries where one million or more COVID-19cases were registered, and the
Prasanta Kumar Ghosh
doaj   +1 more source

Genomic variations associated with attenuation in Mycobacterium avium subsp paratuberculosis vaccine strains [PDF]

open access: yes, 2013
BACKGROUND: Mycobacterium avium subspecies paratuberculosis (MAP) whole cell vaccines have been widely used tools in the control of Johne's disease in animals despite being unable to provide complete protection. Current vaccine strains derive from stocks
Bull, TJ   +7 more
core   +1 more source

Additional Serotypes of Mycobacterium scrofulaceum, Mycobacterium gordonae, Mycobacterium marinum, and Mycobacterium xenopi Determined by Agglutination [PDF]

open access: yesInternational Journal of Systematic Bacteriology, 1976
Agglutination serotypes were investigated by testing mycobacterial cultures from various sources with a large battery of antisera raised in rabbits. Absorption of agglutinins was performed when necessary to clarify serological relationships. Types in addition to those already described were recognized as follows: Mycobacterium scrofulaceum, serotype ...
Emanuel Wolinsky   +2 more
openaire   +2 more sources

In vitro activity of bedaquiline against rapidly growing nontuberculous mycobacteria [PDF]

open access: yes, 2017
Bedaquiline (BDQ) has been proven to be effective in the treatment of multidrug-resistant tuberculosis. We hypothesized that BDQ could be a potential agent to treat nontuberculous mycobacterial (NTM) infection. The objective of this study was to evaluate
Aguilar-Ayala, Diana   +7 more
core   +2 more sources

Isolation, identification, and structural analysis of the mycobactins of Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium scrofulaceum, and Mycobacterium paratuberculosis [PDF]

open access: yesJournal of Bacteriology, 1985
Methods were devised to purify the cell-associated, iron-binding compounds known as mycobactins from the closely related species Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum (i.e., the MAIS complex of organisms). The mycobactins from these three species showed a structure that is common to the mycobactins from all ...
R Barclay, Colin Ratledge, D F Ewing
openaire   +3 more sources

Advances in Cardiovascular Disease Lipid Research Can Provide Novel Insights Into Mycobacterial Pathogenesis

open access: yesFrontiers in Cellular and Infection Microbiology, 2019
Cardiovascular disease (CVD) is the leading cause of death in industrialized nations and an emerging health problem in the developing world. Systemic inflammatory processes associated with alterations in lipid metabolism are a major contributing factor ...
Shyamala Thirunavukkarasu   +1 more
doaj   +1 more source

In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates

open access: yesMicrobiology Spectrum
Non-tuberculosis mycobacteria (NTM), particularly Mycobacterium abscessus subsp. abscessus (M. abscessus), are increasingly being recognized as etiological agents of NTM pulmonary disease. However, treatment options for M.
Izumi Yamatani   +12 more
doaj   +1 more source

Characterization of Mycobacterium chelonae-Like Strains by Comparative Genomics

open access: yesFrontiers in Microbiology, 2017
Isolates of the Mycobacterium chelonae-M. abscessus complex are subdivided into four clusters (CHI to CHIV) in the INNO-LiPA® Mycobacterium spp DNA strip assay. A considerable phenotypic variability was observed among isolates of the CHII cluster.
Christiane L. Nogueira   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy